Recruitment of ethnic minorities into cancer clinical trials: experience from the front lines View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-05-31

AUTHORS

R P Symonds, K Lord, A J Mitchell, D Raghavan

ABSTRACT

Throughout the world there are problems recruiting ethnic minority patients into cancer clinical trials. A major barrier to trial entry may be distrust of research and the medical system. This may be compounded by the regulatory framework governing research with an emphasis on written consent, closed questions and consent documentation, as well as fiscal issues. The Leicester UK experience is that trial accrual is better if British South Asian patients are approached by a senior doctor rather than someone of perceived lesser hierarchical status and a greater partnership between the hospital and General Practitioner may increase trial participation of this particular ethnic minority. In Los Angeles, USA, trial recruitment was improved by a greater utilisation of Hispanic staff and a Spanish language-based education programme. Involvement of community leaders is essential. While adhering to national, legal and ethnical standards, information sheets and consent, it helps if forms can be tailored towards the local ethnic minority population. Written translations are often of limited value in the recruitment of patients with no or limited knowledge of English. In some cultural settings, tape-recorded verbal consent (following approval presentations) may be an acceptable substitute for written consent, and appropriate legislative changes should be considered to facilitate this option. Approaches should be tailored to specific minority populations, taking consideration of their unique characteristics and with input from their community leadership. More... »

PAGES

1017-1021

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.2012.240

DOI

http://dx.doi.org/10.1038/bjc.2012.240

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1016018966

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23011540


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Minority Groups", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Selection", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Cancer Studies & Molecular Medicine, University of Leicester, Osborne Building, Leicester Royal Infirmary, Leicester LE1 5WW, UK", 
          "id": "http://www.grid.ac/institutes/grid.419248.2", 
          "name": [
            "Department of Cancer Studies & Molecular Medicine, University of Leicester, Osborne Building, Leicester Royal Infirmary, Leicester LE1 5WW, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Symonds", 
        "givenName": "R P", 
        "id": "sg:person.01010634573.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010634573.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, Leicester LE1 5WW, UK", 
          "id": "http://www.grid.ac/institutes/grid.419248.2", 
          "name": [
            "University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, Leicester LE1 5WW, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lord", 
        "givenName": "K", 
        "id": "sg:person.01172647657.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172647657.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Leicestershire Partnership Trust, Leicester LE5 0TD, UK", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Cancer Studies & Molecular Medicine, University of Leicester, Osborne Building, Leicester Royal Infirmary, Leicester LE1 5WW, UK", 
            "Leicestershire Partnership Trust, Leicester LE5 0TD, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mitchell", 
        "givenName": "A J", 
        "id": "sg:person.014362211542.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014362211542.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC 28232-2861, USA", 
          "id": "http://www.grid.ac/institutes/grid.468189.a", 
          "name": [
            "University of North Carolina School of Medicine, PO Box 32861, Charlotte, NC 28232-2861, USA", 
            "Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC 28232-2861, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Raghavan", 
        "givenName": "D", 
        "id": "sg:person.01231133345.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231133345.91"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1471-2288-8-64", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047367825", 
          "https://doi.org/10.1186/1471-2288-8-64"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-010-0829-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005008545", 
          "https://doi.org/10.1007/s00520-010-0829-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13187-009-0032-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029652219", 
          "https://doi.org/10.1007/s13187-009-0032-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2011.69", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024392544", 
          "https://doi.org/10.1038/bjc.2011.69"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6601774", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005723318", 
          "https://doi.org/10.1038/sj.bjc.6601774"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-05-31", 
    "datePublishedReg": "2012-05-31", 
    "description": "Throughout the world there are problems recruiting ethnic minority patients into cancer clinical trials. A major barrier to trial entry may be distrust of research and the medical system. This may be compounded by the regulatory framework governing research with an emphasis on written consent, closed questions and consent documentation, as well as fiscal issues. The Leicester UK experience is that trial accrual is better if British South Asian patients are approached by a senior doctor rather than someone of perceived lesser hierarchical status and a greater partnership between the hospital and General Practitioner may increase trial participation of this particular ethnic minority. In Los Angeles, USA, trial recruitment was improved by a greater utilisation of Hispanic staff and a Spanish language-based education programme. Involvement of community leaders is essential. While adhering to national, legal and ethnical standards, information sheets and consent, it helps if forms can be tailored towards the local ethnic minority population. Written translations are often of limited value in the recruitment of patients with no or limited knowledge of English. In some cultural settings, tape-recorded verbal consent (following approval presentations) may be an acceptable substitute for written consent, and appropriate legislative changes should be considered to facilitate this option. Approaches should be tailored to specific minority populations, taking consideration of their unique characteristics and with input from their community leadership.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/bjc.2012.240", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "107"
      }
    ], 
    "keywords": [
      "cancer clinical trials", 
      "clinical trials", 
      "South Asian patients", 
      "recruitment of patients", 
      "ethnic minority patients", 
      "minority populations", 
      "trial entry", 
      "Asian patients", 
      "trial participation", 
      "minority patients", 
      "general practitioners", 
      "trial recruitment", 
      "verbal consent", 
      "ethnic minorities", 
      "patients", 
      "ethnic minority populations", 
      "senior doctors", 
      "trials", 
      "distrust of research", 
      "information sheet", 
      "specific minority populations", 
      "particular ethnic minority", 
      "consent", 
      "limited value", 
      "consent documentation", 
      "cultural settings", 
      "medical system", 
      "greater partnership", 
      "major barrier", 
      "acceptable substitute", 
      "hierarchical status", 
      "recruitment", 
      "hospital", 
      "education programs", 
      "limited knowledge", 
      "population", 
      "front line", 
      "community leaders", 
      "doctors", 
      "minority", 
      "Los Angeles", 
      "greater utilisation", 
      "UK experience", 
      "community leadership", 
      "involvement", 
      "English", 
      "status", 
      "options", 
      "staff", 
      "setting", 
      "translation", 
      "world", 
      "practitioners", 
      "entry", 
      "research", 
      "distrust", 
      "barriers", 
      "questions", 
      "documentation", 
      "experience", 
      "changes", 
      "participation", 
      "Angeles", 
      "program", 
      "legislative changes", 
      "issues", 
      "utilisation", 
      "leaders", 
      "unique characteristics", 
      "form", 
      "substitute", 
      "lines", 
      "standards", 
      "knowledge", 
      "emphasis", 
      "leadership", 
      "partnership", 
      "fiscal issues", 
      "characteristics", 
      "framework", 
      "USA", 
      "values", 
      "consideration", 
      "regulatory framework", 
      "approach", 
      "system", 
      "problem", 
      "input", 
      "sheets", 
      "appropriate legislative changes", 
      "Leicester UK experience", 
      "British South Asian patients", 
      "lesser hierarchical status", 
      "Hispanic staff", 
      "Spanish language-based education programme", 
      "language-based education programme", 
      "ethnical standards", 
      "local ethnic minority population", 
      "tape-recorded verbal consent"
    ], 
    "name": "Recruitment of ethnic minorities into cancer clinical trials: experience from the front lines", 
    "pagination": "1017-1021", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1016018966"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.2012.240"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23011540"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.2012.240", 
      "https://app.dimensions.ai/details/publication/pub.1016018966"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:26", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_557.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/bjc.2012.240"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.2012.240'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.2012.240'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.2012.240'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.2012.240'


 

This table displays all metadata directly associated to this object as RDF triples.

236 TRIPLES      22 PREDICATES      136 URIs      122 LITERALS      12 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.2012.240 schema:about N17934112c0a04468b722875342e7c03d
2 N1ee012f2eb7c485795d03ec866071fb0
3 N4f8b1547cb1d49f68fa84a8556a6e09f
4 N5ceeb70fe5bb458d8076d7d51e06072c
5 Nfb8d4b57a4414f41aa25627c0966c0ca
6 anzsrc-for:11
7 anzsrc-for:1112
8 anzsrc-for:1117
9 schema:author N957eda88e47a4646a9cbbad664f450a9
10 schema:citation sg:pub.10.1007/s00520-010-0829-6
11 sg:pub.10.1007/s13187-009-0032-y
12 sg:pub.10.1038/bjc.2011.69
13 sg:pub.10.1038/sj.bjc.6601774
14 sg:pub.10.1186/1471-2288-8-64
15 schema:datePublished 2012-05-31
16 schema:datePublishedReg 2012-05-31
17 schema:description Throughout the world there are problems recruiting ethnic minority patients into cancer clinical trials. A major barrier to trial entry may be distrust of research and the medical system. This may be compounded by the regulatory framework governing research with an emphasis on written consent, closed questions and consent documentation, as well as fiscal issues. The Leicester UK experience is that trial accrual is better if British South Asian patients are approached by a senior doctor rather than someone of perceived lesser hierarchical status and a greater partnership between the hospital and General Practitioner may increase trial participation of this particular ethnic minority. In Los Angeles, USA, trial recruitment was improved by a greater utilisation of Hispanic staff and a Spanish language-based education programme. Involvement of community leaders is essential. While adhering to national, legal and ethnical standards, information sheets and consent, it helps if forms can be tailored towards the local ethnic minority population. Written translations are often of limited value in the recruitment of patients with no or limited knowledge of English. In some cultural settings, tape-recorded verbal consent (following approval presentations) may be an acceptable substitute for written consent, and appropriate legislative changes should be considered to facilitate this option. Approaches should be tailored to specific minority populations, taking consideration of their unique characteristics and with input from their community leadership.
18 schema:genre article
19 schema:inLanguage en
20 schema:isAccessibleForFree true
21 schema:isPartOf N53e268acda644f61b82cafafb2faf33c
22 N8e70865d107047c59f6a2dadb4265e44
23 sg:journal.1017082
24 schema:keywords Angeles
25 Asian patients
26 British South Asian patients
27 English
28 Hispanic staff
29 Leicester UK experience
30 Los Angeles
31 South Asian patients
32 Spanish language-based education programme
33 UK experience
34 USA
35 acceptable substitute
36 approach
37 appropriate legislative changes
38 barriers
39 cancer clinical trials
40 changes
41 characteristics
42 clinical trials
43 community leaders
44 community leadership
45 consent
46 consent documentation
47 consideration
48 cultural settings
49 distrust
50 distrust of research
51 doctors
52 documentation
53 education programs
54 emphasis
55 entry
56 ethnic minorities
57 ethnic minority patients
58 ethnic minority populations
59 ethnical standards
60 experience
61 fiscal issues
62 form
63 framework
64 front line
65 general practitioners
66 greater partnership
67 greater utilisation
68 hierarchical status
69 hospital
70 information sheet
71 input
72 involvement
73 issues
74 knowledge
75 language-based education programme
76 leaders
77 leadership
78 legislative changes
79 lesser hierarchical status
80 limited knowledge
81 limited value
82 lines
83 local ethnic minority population
84 major barrier
85 medical system
86 minority
87 minority patients
88 minority populations
89 options
90 participation
91 particular ethnic minority
92 partnership
93 patients
94 population
95 practitioners
96 problem
97 program
98 questions
99 recruitment
100 recruitment of patients
101 regulatory framework
102 research
103 senior doctors
104 setting
105 sheets
106 specific minority populations
107 staff
108 standards
109 status
110 substitute
111 system
112 tape-recorded verbal consent
113 translation
114 trial entry
115 trial participation
116 trial recruitment
117 trials
118 unique characteristics
119 utilisation
120 values
121 verbal consent
122 world
123 schema:name Recruitment of ethnic minorities into cancer clinical trials: experience from the front lines
124 schema:pagination 1017-1021
125 schema:productId N64bc456d4b9d4c97bc0194c64f4e862d
126 Ncfe20a831ac64821a2aed7fefe0a5068
127 Nd1774aeeab3a464b87777f646a3ad370
128 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016018966
129 https://doi.org/10.1038/bjc.2012.240
130 schema:sdDatePublished 2021-12-01T19:26
131 schema:sdLicense https://scigraph.springernature.com/explorer/license/
132 schema:sdPublisher N4739a3dc45fd43d9b9984d1242b7fc67
133 schema:url https://doi.org/10.1038/bjc.2012.240
134 sgo:license sg:explorer/license/
135 sgo:sdDataset articles
136 rdf:type schema:ScholarlyArticle
137 N17934112c0a04468b722875342e7c03d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Neoplasms
139 rdf:type schema:DefinedTerm
140 N1ee012f2eb7c485795d03ec866071fb0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Humans
142 rdf:type schema:DefinedTerm
143 N3a0a7155d72748cdb1cf43ced42d691a rdf:first sg:person.01231133345.91
144 rdf:rest rdf:nil
145 N4739a3dc45fd43d9b9984d1242b7fc67 schema:name Springer Nature - SN SciGraph project
146 rdf:type schema:Organization
147 N4f8b1547cb1d49f68fa84a8556a6e09f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Minority Groups
149 rdf:type schema:DefinedTerm
150 N53e268acda644f61b82cafafb2faf33c schema:volumeNumber 107
151 rdf:type schema:PublicationVolume
152 N574f86775ccc4a6ea890c5baf5471fa4 rdf:first sg:person.014362211542.45
153 rdf:rest N3a0a7155d72748cdb1cf43ced42d691a
154 N5ceeb70fe5bb458d8076d7d51e06072c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Patient Selection
156 rdf:type schema:DefinedTerm
157 N64bc456d4b9d4c97bc0194c64f4e862d schema:name doi
158 schema:value 10.1038/bjc.2012.240
159 rdf:type schema:PropertyValue
160 N8e70865d107047c59f6a2dadb4265e44 schema:issueNumber 7
161 rdf:type schema:PublicationIssue
162 N957eda88e47a4646a9cbbad664f450a9 rdf:first sg:person.01010634573.67
163 rdf:rest Nc10c75c77eb34e1a9e2e7afc0dac4e99
164 Nc10c75c77eb34e1a9e2e7afc0dac4e99 rdf:first sg:person.01172647657.44
165 rdf:rest N574f86775ccc4a6ea890c5baf5471fa4
166 Ncfe20a831ac64821a2aed7fefe0a5068 schema:name dimensions_id
167 schema:value pub.1016018966
168 rdf:type schema:PropertyValue
169 Nd1774aeeab3a464b87777f646a3ad370 schema:name pubmed_id
170 schema:value 23011540
171 rdf:type schema:PropertyValue
172 Nfb8d4b57a4414f41aa25627c0966c0ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Clinical Trials as Topic
174 rdf:type schema:DefinedTerm
175 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
176 schema:name Medical and Health Sciences
177 rdf:type schema:DefinedTerm
178 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
179 schema:name Oncology and Carcinogenesis
180 rdf:type schema:DefinedTerm
181 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
182 schema:name Public Health and Health Services
183 rdf:type schema:DefinedTerm
184 sg:journal.1017082 schema:issn 0007-0920
185 1532-1827
186 schema:name British Journal of Cancer
187 schema:publisher Springer Nature
188 rdf:type schema:Periodical
189 sg:person.01010634573.67 schema:affiliation grid-institutes:grid.419248.2
190 schema:familyName Symonds
191 schema:givenName R P
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010634573.67
193 rdf:type schema:Person
194 sg:person.01172647657.44 schema:affiliation grid-institutes:grid.419248.2
195 schema:familyName Lord
196 schema:givenName K
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172647657.44
198 rdf:type schema:Person
199 sg:person.01231133345.91 schema:affiliation grid-institutes:grid.468189.a
200 schema:familyName Raghavan
201 schema:givenName D
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231133345.91
203 rdf:type schema:Person
204 sg:person.014362211542.45 schema:affiliation grid-institutes:None
205 schema:familyName Mitchell
206 schema:givenName A J
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014362211542.45
208 rdf:type schema:Person
209 sg:pub.10.1007/s00520-010-0829-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005008545
210 https://doi.org/10.1007/s00520-010-0829-6
211 rdf:type schema:CreativeWork
212 sg:pub.10.1007/s13187-009-0032-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1029652219
213 https://doi.org/10.1007/s13187-009-0032-y
214 rdf:type schema:CreativeWork
215 sg:pub.10.1038/bjc.2011.69 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024392544
216 https://doi.org/10.1038/bjc.2011.69
217 rdf:type schema:CreativeWork
218 sg:pub.10.1038/sj.bjc.6601774 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005723318
219 https://doi.org/10.1038/sj.bjc.6601774
220 rdf:type schema:CreativeWork
221 sg:pub.10.1186/1471-2288-8-64 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047367825
222 https://doi.org/10.1186/1471-2288-8-64
223 rdf:type schema:CreativeWork
224 grid-institutes:None schema:alternateName Leicestershire Partnership Trust, Leicester LE5 0TD, UK
225 schema:name Department of Cancer Studies & Molecular Medicine, University of Leicester, Osborne Building, Leicester Royal Infirmary, Leicester LE1 5WW, UK
226 Leicestershire Partnership Trust, Leicester LE5 0TD, UK
227 rdf:type schema:Organization
228 grid-institutes:grid.419248.2 schema:alternateName Department of Cancer Studies & Molecular Medicine, University of Leicester, Osborne Building, Leicester Royal Infirmary, Leicester LE1 5WW, UK
229 University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, Leicester LE1 5WW, UK
230 schema:name Department of Cancer Studies & Molecular Medicine, University of Leicester, Osborne Building, Leicester Royal Infirmary, Leicester LE1 5WW, UK
231 University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, Leicester LE1 5WW, UK
232 rdf:type schema:Organization
233 grid-institutes:grid.468189.a schema:alternateName Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC 28232-2861, USA
234 schema:name Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC 28232-2861, USA
235 University of North Carolina School of Medicine, PO Box 32861, Charlotte, NC 28232-2861, USA
236 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...